☰

Alina Molchadsky, Ph.D. - Publications

Affiliations: 
2011 Weizmann Institute of Science, Rehovot, Israel 
Area:
Cell Biology, Biochemistry, Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Koifman G, Shetzer Y, Eizenberger S, Solomon H, Rotkopf R, Molchadsky A, Lonetto G, Goldfinger N, Rotter V. A mutant p53-dependent embryonic stem cell gene signature is associated with augmented tumorigenesis of stem cells. Cancer Research. PMID 30154152 DOI: 10.1158/0008-5472.Can-18-0805  0.71
2018 Charni-Natan M, Solomon H, Molchadsky A, Jacob-Berger A, Goldfinger N, Rotter V. Various stress stimuli rewire the profile of liver secretome in a p53-dependent manner. Cell Death & Disease. 9: 647. PMID 29844359 DOI: 10.1038/S41419-018-0697-4  0.639
2018 Solomon H, Dinowitz N, Pateras IS, Cooks T, Shetzer Y, Molchadsky A, Charni M, Rabani S, Koifman G, Tarcic O, Porat Z, Kogan-Sakin I, Goldfinger N, Oren M, Harris CC, et al. Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers. Oncogene. PMID 29343849 DOI: 10.1038/S41388-017-0060-8  0.718
2017 Prokocimer M, Molchadsky A, Rotter V. Dysfunctional diversity of p53 proteins in adult acute myeloid leukemia: projections on diagnostic work-up and therapy. Blood. PMID 28607134 DOI: 10.1182/Blood-2017-02-763086  0.696
2017 Molchadsky A, Rotter V. p53 and its mutants on the slippery road from stemness to carcinogenesis. Carcinogenesis. PMID 28334334 DOI: 10.1093/Carcin/Bgw092  0.713
2016 Grespi F, LandrĂ© V, Molchadsky A, Di Daniele N, Marsella LT, Melino G, Rotter V. Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cells. Cell Death & Disease. 7: e2567. PMID 28032868 DOI: 10.1038/Cddis.2016.419  0.73
2016 Shetzer Y, Napchan Y, Kaufman T, Molchadsky A, Tal P, Goldfinger N, Rotter V. Immune deficiency augments the prevalence of p53 loss of heterozygosity in spontaneous tumors but not bi-directional loss of heterozygosity in bone marrow progenitors. International Journal of Cancer. PMID 28008605 DOI: 10.1002/Ijc.30554  0.664
2016 Charni M, Aloni-Grinstein R, Molchadsky A, Rotter V. p53 on the crossroad between regeneration and cancer. Cell Death and Differentiation. PMID 27768121 DOI: 10.1038/Cdd.2016.117  0.653
2016 Shetzer Y, Molchadsky A, Rotter V. Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation. Cold Spring Harbor Perspectives in Medicine. PMID 27235476 DOI: 10.1101/Cshperspect.A026203  0.724
2015 Charni M, Molchadsky A, Goldstein I, Solomon H, Tal P, Goldfinger N, Yang P, Porat Z, Lozano G, Rotter V. Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation. Cell Death and Differentiation. PMID 26358154 DOI: 10.1038/Cdd.2015.119  0.722
2014 Charni M, Rivlin N, Molchadsky A, Aloni-Grinstein R, Rotter V. p53 in liver pathologies-taking the good with the bad. Journal of Molecular Medicine (Berlin, Germany). 92: 1229-34. PMID 25404244 DOI: 10.1007/S00109-014-1223-5  0.657
2014 Shetzer Y, Kagan S, Koifman G, Sarig R, Kogan-Sakin I, Charni M, Kaufman T, Zapatka M, Molchadsky A, Rivlin N, Dinowitz N, Levin S, Landan G, Goldstein I, Goldfinger N, et al. The onset of p53 loss of heterozygosity is differentially induced in various stem cell types and may involve the loss of either allele. Cell Death and Differentiation. 21: 1419-31. PMID 24832469 DOI: 10.1038/Cdd.2014.57  0.688
2014 Rivlin N, Katz S, Doody M, Sheffer M, Horesh S, Molchadsky A, Koifman G, Shetzer Y, Goldfinger N, Rotter V, Geiger T. Rescue of embryonic stem cells from cellular transformation by proteomic stabilization of mutant p53 and conversion into WT conformation. Proceedings of the National Academy of Sciences of the United States of America. 111: 7006-11. PMID 24778235 DOI: 10.1073/Pnas.1320428111  0.746
2014 Shetzer Y, Solomon H, Koifman G, Molchadsky A, Horesh S, Rotter V. The paradigm of mutant p53-expressing cancer stem cells and drug resistance. Carcinogenesis. 35: 1196-208. PMID 24658181 DOI: 10.1093/Carcin/Bgu073  0.711
2013 Molchadsky A, Ezra O, Amendola PG, Krantz D, Kogan-Sakin I, Buganim Y, Rivlin N, Goldfinger N, Folgiero V, Falcioni R, Sarig R, Rotter V. p53 is required for brown adipogenic differentiation and has a protective role against diet-induced obesity. Cell Death and Differentiation. 20: 774-83. PMID 23412343 DOI: 10.1038/Cdd.2013.9  0.693
2013 Brosh R, Assia-Alroy Y, Molchadsky A, Bornstein C, Dekel E, Madar S, Shetzer Y, Rivlin N, Goldfinger N, Sarig R, Rotter V. p53 counteracts reprogramming by inhibiting mesenchymal-to-epithelial transition. Cell Death and Differentiation. 20: 312-20. PMID 22996684 DOI: 10.1038/Cdd.2012.125  0.749
2012 Landan G, Cohen NM, Mukamel Z, Bar A, Molchadsky A, Brosh R, Horn-Saban S, Zalcenstein DA, Goldfinger N, Zundelevich A, Gal-Yam EN, Rotter V, Tanay A. Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues. Nature Genetics. 44: 1207-14. PMID 23064413 DOI: 10.1038/Ng.2442  0.497
2012 Goldstein I, Ezra O, Rivlin N, Molchadsky A, Madar S, Goldfinger N, Rotter V. p53, a novel regulator of lipid metabolism pathways. Journal of Hepatology. 56: 656-62. PMID 22037227 DOI: 10.1186/1753-6561-6-S3-P61  0.693
2011 Rinon A, Molchadsky A, Nathan E, Yovel G, Rotter V, Sarig R, Tzahor E. p53 coordinates cranial neural crest cell growth and epithelial-mesenchymal transition/delamination processes. Development (Cambridge, England). 138: 1827-38. PMID 21447558 DOI: 10.1242/Dev.053645  0.706
2011 Bornstein C, Brosh R, Molchadsky A, Madar S, Kogan-Sakin I, Goldstein I, Chakravarti D, Flores ER, Goldfinger N, Sarig R, Rotter V. SPATA18, a spermatogenesis-associated gene, is a novel transcriptional target of p53 and p63. Molecular and Cellular Biology. 31: 1679-89. PMID 21300779 DOI: 10.1128/Mcb.01072-10  0.718
2011 Kogan-Sakin I, Tabach Y, Buganim Y, Molchadsky A, Solomon H, Madar S, Kamer I, Stambolsky P, Shelly A, Goldfinger N, Valsesia-Wittmann S, Puisieux A, Zundelevich A, Gal-Yam EN, Avivi C, et al. Mutant p53(R175H) upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells. Cell Death and Differentiation. 18: 271-81. PMID 20689556 DOI: 10.1038/Cdd.2010.94  0.763
2010 Sarig R, Rivlin N, Brosh R, Bornstein C, Kamer I, Ezra O, Molchadsky A, Goldfinger N, Brenner O, Rotter V. Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells. The Journal of Experimental Medicine. 207: 2127-40. PMID 20696700 DOI: 10.1084/Jem.20100797  0.759
2010 Molchadsky A, Rivlin N, Brosh R, Rotter V, Sarig R. p53 is balancing development, differentiation and de-differentiation to assure cancer prevention. Carcinogenesis. 31: 1501-8. PMID 20504879 DOI: 10.1093/Carcin/Bgq101  0.74
2010 Brosh R, Sarig R, Natan EB, Molchadsky A, Madar S, Bornstein C, Buganim Y, Shapira T, Goldfinger N, Paus R, Rotter V. p53-dependent transcriptional regulation of EDA2R and its involvement in chemotherapy-induced hair loss. Febs Letters. 584: 2473-7. PMID 20434500 DOI: 10.1016/J.Febslet.2010.04.058  0.709
2009 Kogan-Sakin I, Cohen M, Paland N, Madar S, Solomon H, Molchadsky A, Brosh R, Buganim Y, Goldfinger N, Klocker H, Schalken JA, Rotter V. Prostate stromal cells produce CXCL-1, CXCL-2, CXCL-3 and IL-8 in response to epithelia-secreted IL-1. Carcinogenesis. 30: 698-705. PMID 19233959 DOI: 10.1093/Carcin/Bgp043  0.549
2008 Molchadsky A, Shats I, Goldfinger N, Pevsner-Fischer M, Olson M, Rinon A, Tzahor E, Lozano G, Zipori D, Sarig R, Rotter V. p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner. Plos One. 3: e3707. PMID 19002260 DOI: 10.1371/Journal.Pone.0003707  0.67
Show low-probability matches.